Cargando…

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis

BACKGROUND: Fatigue is prevalent and impactful in rheumatoid arthritis (RA). There is no standardized measure for its assessment nor data concerning the performance of PROMIS-Fatigue short forms (SFs) in people with RA. We evaluated the construct validity of 4-, 7-, and 8-item PROMIS-Fatigue SFs in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bingham III, Clifton O., Gutierrez, Anna Kristina, Butanis, Alessandra, Bykerk, Vivian P., Curtis, Jeffrey R., Leong, Amye, Lyddiatt, Anne, Nowell, W. Benjamin, Orbai, Ana Maria, Bartlett, Susan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384289/ https://www.ncbi.nlm.nih.gov/pubmed/30790155 http://dx.doi.org/10.1186/s41687-019-0105-6

Ejemplares similares

Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis
por: Bartlett, Susan J., et al.
Publicado: (2015)

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
por: Bykerk, Vivian P, et al.
Publicado: (2016)

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
por: Bingham, Clifton O., et al.
Publicado: (2023)

Test–Retest Reliability and Responsiveness of PROMIS Sleep Short Forms Within an RCT in Women With Fibromyalgia
por: Chimenti, Ruth L., et al.
Publicado: (2021)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain
por: Pokrzywinski, Robin, et al.
Publicado: (2020)

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2022)

Interview Administration of PROMIS Depression and Anxiety Short Forms
por: Taple, Bayley J., et al.
Publicado: (2019)

Validity assessment of the PROMIS fatigue domain among people living with HIV
por: Gibbons, L. E., et al.
Publicado: (2017)

The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials
por: Bartlett, Susan J., et al.
Publicado: (2022)

Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS® sleep and pain short forms
por: Yang, Manshu, et al.
Publicado: (2022)

Data‐Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015)

Psychometric validation of the Chinese version of the PROMIS Social Relationships Short Forms
por: Cai, Tingting, et al.
Publicado: (2021)

Development of the PROMIS-based Research Assessment and Clinical Tool-Fatigue (ReACT-F)
por: Dickinson, Kristin A., et al.
Publicado: (2019)

Calibration of the PROMIS Physical Function Item Bank in Dutch Patients with Rheumatoid Arthritis
por: Oude Voshaar, Martijn A. H., et al.
Publicado: (2014)

Assessing fatigue in children and adolescents: Psychometric validation of the German version of the PROMIS(®) Pediatric Short Form v2.0 - Fatigue 10a in school children and pediatric chronic pain patients
por: Sommer, Ariane, et al.
Publicado: (2021)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

The development and initial validation of the PROMIS®+HF‐27 and PROMIS+HF‐10 profiles
por: Ahmad, Faraz S., et al.
Publicado: (2022)

Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry
por: Sebba, Anthony, et al.
Publicado: (2023)

Psychometric evaluation of the PROMIS social function short forms in Chinese patients with breast cancer
por: Cai, Tingting, et al.
Publicado: (2021)

Measurement properties of PROMIS short forms for pain and function in total hip arthroplasty patients
por: Stephan, Anika, et al.
Publicado: (2021)

Measurement properties of PROMIS short forms for pain and function in patients receiving knee arthroplasty
por: Stephan, Anika, et al.
Publicado: (2023)

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
por: Weinblatt, Michael E., et al.
Publicado: (2017)

Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease
por: Feagan, Brian G., et al.
Publicado: (2023)

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
por: Cappelli, Laura C., et al.
Publicado: (2020)

Implementation of PROMIS(®) in an Optometry Clinic
por: Porter, Randall S, et al.
Publicado: (2021)

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study
por: Emery, Paul, et al.
Publicado: (2023)

Correction: Measurement properties of PROMIS short forms for pain and function in patients receiving knee arthroplasty
por: Stephan, Anika, et al.
Publicado: (2023)

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
por: Emery, Paul, et al.
Publicado: (2023)

German translation of the PROMIS(®) pediatric anxiety, anger, depressive symptoms, fatigue, pain interference and peer relationships item banks
por: Devine, J., et al.
Publicado: (2023)

Clinical and PROMIS Outcomes of Maisonneuve Fractures
por: Andrews, Nicholas A., et al.
Publicado: (2022)

Expected a posteriori scoring in PROMIS(®)
por: Chapman, Robert
Publicado: (2022)

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
por: Alten, Rieke, et al.
Publicado: (2016)

Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease
por: Mason, Sadie F., et al.
Publicado: (2023)

Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis
por: Wu, Chun, et al.
Publicado: (2022)

Treatment goals for rheumatoid arthritis: patient engagement and goal collection
por: Predmore, Zachary, et al.
Publicado: (2023)

Mechanics of fretting fatigue
por: Hills, D A, et al.
Publicado: (1994)

Fatigue in rheumatoid arthritis
por: Choy, Ernest H, et al.
Publicado: (2019)

A quarter of patients time their early rheumatoid arthritis onset differently than physicians
por: Ellingwood, Leah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1tvk88oqjre5iqgd5agjnon0p1